Source: MarketScreener

BERG: BERG To Present Latest Glioblastoma [GBM] Treatment Data At Society For Neuro-Onocology 2021 Meeting

(marketscreener.com) FRAMINGHAM, Mass., July 14, 2021 /PRNewswire/ -- BERG, a clinical-stage biotech that employs patient biology and artificial intelligence to research diseases and develop innovative treatments, will present two poster presentations at the Society for Neuro-Oncology: Basic and Translational Omics of Brain Tumors and Their Microenvironment...https://www.marketscreener.com/news/latest/BERG-To-Present-Latest-Glioblastoma-GBM-Treatment-Data-At-Society-For-Neuro-Onocology-2021-Meeting--35858643/?utm_medium=RSS&utm_content=20210714

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Niven R. Narain's photo - President & CEO of BERG

President & CEO

Niven R. Narain

CEO Approval Rating

89/100

Read more